Dr. Chao Huang currently serves as the Director of the Lung Program at the University of Kansas Medical Center and Associate Professor of Medicine at KU Medical Center. As the director of the program, Dr. Huang leads a team of multidiscplinary experts to provide patients with the latest medical advancements. The program also has a mission to better educate the public on prevention and early detection of lung diseases like mesothelioma.
Dr. Huang’s research revolves around cancers of the lung, head, and neck, with a particular interest in clinical trials and translational research. Dr. Huang has authored or coauthored scientific articles in several journals, including the Journal of Thoracic Oncology, the Journal of Clinical Oncology, Frontiers in Oncology, Lung Cancer and Oncology Reports.
Main Specialty: Medical Oncology
Other Interests & Specialties: Hematologic oncology, brain cancer, cancer pain, breast cancer, chest cancers, esophageal cancer, head and neck cancer, lung cancer, throat cancer, pancreatic cancer, stomach cancer, liver cancer, lung masses, lymphoma, metastatic lung malignancy, multiple myeloma and thoracic malignancy.
Certifications, Awards & Accolades: American Board of Internal Medicine Certification in Hematology, American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Certification in Medical Oncology, Infectious Disease Research Award, Leonard N. Horowitz, M.D. Memorial Award, Special Contribution Award in Teaching, CARES Award, Top Doc Award, member of the American College of Physicians, member of the American Association for Cancer Research (AACR), member of the American Society of Clinical Oncology (ASCO), member of the American Society of Hematology (ASH), member of the Southwest Oncology Group (SWOG), member of the International Association for the Study of Lung Cancer (IASLC)
Education & Experience:
- Medical Degree from Faculdade de Medicina, Universidade Federal do Grande do Sul
- Internship for Internal Medicine at Presbyterian Medical Center
- Residency in Internal Medicine at University of Pennsylvania Health System
- Chief Residency for Internal Medicine at Presbyterian Medical Center of University of Pennsylvania Health System
- Fellowship for Hematology Oncology at Fox Chase Cancer Center and Temple University Hospital
Lung Cancer Management in 2010. Oncology (Williston Park). January 2011;25(1):64-73.
Topotecan in the treatment of relapsed small cell lung cancer patients with poor performance status. The Oncologist. 2004;9(2):173-81.
Dysgenetic hypoplastic kidney simulating metastatic lung carcinoma. Lung Cancer (Amsterdam, Netherlands). October 2006;54(1):125-9. doi: 10.1016/j.lungcan.2006.06.020